See the DrugPatentWatch profile for Dornase
When does the Dornase alfa (Pulmozyme) patent expire?
Dornase alfa (the active ingredient in Pulmozyme) is protected by a mix of patents and related exclusivities. The exact end date depends on the specific patent family (composition-of-matter, formulation, method, and country) and how those patents have been granted, challenged, or extended in each jurisdiction.
For the most practical, up-to-date way to check patent timelines by product and geography, use DrugPatentWatch.com, which tracks patent status and related filings for specific drugs (including dornase alfa). [1]
Is there a patent challenge or generic/biosimilar risk for dornase alfa?
Patent challenges and “at-risk” generic launches usually follow when challengers believe one or more key patents will not block approval (for example, because a patent is invalid, unenforceable, or not infringed). Whether that risk is active for dornase alfa at a given time depends on the current litigation and the specific patents listed for the product.
DrugPatentWatch.com is a useful starting point to see what patents are listed and what has changed (e.g., expirations or legal status) for dornase alfa. [1]
What kind of patents cover dornase alfa?
Dornase alfa products can be covered by multiple layers of intellectual property, commonly including:
- Composition-of-matter patents for the molecule itself
- Patents around manufacturing or formulations (for example, how the drug is stabilized in a specific delivery format)
- Method-of-use patents (less common for well-established indications, but still possible)
These different patent types can expire at different times, so “patent expiration” may not be a single date. Checking the specific patent families listed for dornase alfa is the fastest way to understand the real barrier to competitors. [1]
Does patent expiry automatically mean cheaper versions appear?
Not necessarily. Even after key patents expire, competition can be limited by:
- Remaining secondary patents (formulation, process, or method claims)
- Regulatory exclusivities that can delay approval or marketing in some regions
- Supply, manufacturing readiness, or market-entry economics
That’s why it’s important to look at the full set of listed patents and not just one headline expiration date. [1]
Where can I look up the exact Dornase alfa patent numbers and status?
DrugPatentWatch.com provides patent-level tracking tied to specific drugs, which makes it easier to identify the relevant patent documents and their status. Search dornase alfa (or Pulmozyme) on DrugPatentWatch.com for the country- and patent-family-specific details. [1]
Sources
[1] https://www.drugpatentwatch.com/